Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study
- PMID: 19439328
- PMCID: PMC2728792
- DOI: 10.1016/j.metabol.2009.04.007
Ala54Thr polymorphism of the fatty acid binding protein 2 gene and saturated fat intake in relation to lipid levels and insulin resistance: the Coronary Artery Risk Development in Young Adults (CARDIA) study
Abstract
The Thr54 allele of the intestinal fatty acid-binding protein Ala54Thr functional polymorphism (FABP2) is associated with increased fat oxidation and insulin resistance. We determined the cross-sectional associations of the FABP2 gene with lipid levels and insulin resistance in 2148 participants who completed the year-20 examination of the Coronary Artery Risk Development in Young Adults (CARDIA) study. No significant difference in total cholesterol, low-density or high-density lipoprotein cholesterol, triglycerides, high-density lipoprotein cholesterol to total cholesterol ratio, or homeostasis model assessment of insulin resistance (HOMA-IR) was found between FABP2 genotypes. However, in the presence of a high-saturated fat diet (>/=53.2 g/d, the 90th percentile for the population), the AA/AG genotypes (carriers of the Thr54 allele) of FABP2 had statistically significantly higher levels of log(HOMA-IR) (P = .006) and a lower high-density lipoprotein cholesterol to total cholesterol ratio (P = .03), and borderline statistically significantly higher levels of total cholesterol, low-density lipoprotein cholesterol, and log(triglycerides) (P values = .08, .07, and .05, respectively) compared with those with the GG genotype (Ala54 homozygotes). Lipid levels and log(HOMA-IR) did not vary by genotype with saturated fat intake less than 53.2 g/d. Limiting dietary saturated fat intake may be particularly important among carriers of the A allele of FABP2.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures




References
-
- Li Y, Fisher E, Klapper M, Boeing H, Pfeiffer A, Hampe J, et al. Association between functional FABP2 promoter haplotype and type 2 diabetes. Hormone & Metabolic Research. 2006 May;38(5):300–307. - PubMed
-
- Weiss EP, Brandauer J, Kulaputana O, Ghiu IA, Wohn CR, Phares DA, et al. FABP2 Ala54Thr genotype is associated with glucoregulatory function and lipid oxidation after a high-fat meal in sedentary nondiabetic men and women. Am J Clin Nutr. 2007 January 1;85(1):102–108. - PubMed
-
- Levy E, Menard D, Delvin E, Stan S, Mitchell G, Lambert M, et al. The polymorphism at codon 54 of the FABP2 gene increases fat absorption in human intestinal explants. J Biol Chem. 2001 Oct 26;276(43):39679–39684. - PubMed
-
- Galluzzi JR, Cupples LA, Meigs JB, Wilson PW, Schaefer EJ, Ordovas JM, et al. Association of the Ala54-Thr polymorphism in the intestinal fatty acid-binding protein with 2-h postchallenge insulin levels in the Framingham Offspring Study. Diabetes Care. 2001 Jul;24(7):1161–1166. - PubMed
-
- Marin C, Perez-Jimenez F, Gomez P, Delgado J, Paniagua JA, Lozano A, et al. The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr. 2005 Jul;82(1):196–200. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01-HC-05187/HC/NHLBI NIH HHS/United States
- N01 HC048048/HL/NHLBI NIH HHS/United States
- N01 HC048048/HC/NHLBI NIH HHS/United States
- N01-HC-48047/HC/NHLBI NIH HHS/United States
- N01-HC-95095/HC/NHLBI NIH HHS/United States
- T32-HL-007779/HL/NHLBI NIH HHS/United States
- N01-HC-48049/HC/NHLBI NIH HHS/United States
- N01 HC048047/HL/NHLBI NIH HHS/United States
- N01 HC048050/HL/NHLBI NIH HHS/United States
- N01-HC-48048/HC/NHLBI NIH HHS/United States
- N01 HC045204/HL/NHLBI NIH HHS/United States
- N01 HC095095/HL/NHLBI NIH HHS/United States
- N01-HC-45205/HC/NHLBI NIH HHS/United States
- N01-HC-45204/HC/NHLBI NIH HHS/United States
- N01 HC048049/HL/NHLBI NIH HHS/United States
- N01-HC-48050/HC/NHLBI NIH HHS/United States
- N01 HC045205/HL/NHLBI NIH HHS/United States
- N01 HC005187/HL/NHLBI NIH HHS/United States
- N01 HC045134/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources